Cite
HARVARD Citation
Dearnaley, D. et al. (n.d.). 8LBA 5 year outcomes of a phase III randomised trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CRUK/06/016): report from the CHHiP Trial Investigators Group. European journal of cancer. pp. S712-. [Online].